NTII Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume57.00
Average Volume (3M)N/A
Market Cap
$27.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-55.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,020,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NTII FAQ
What was Neurobiological Technologies Inc’s price range in the past 12 months?
Neurobiological Technologies Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Neurobiological Technologies Inc’s market cap?
Neurobiological Technologies Inc’s market cap is $27.00.
When is Neurobiological Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Neurobiological Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Neurobiological Technologies Inc overvalued?
According to Wall Street analysts Neurobiological Technologies Inc’s price is currently Overvalued.
Does Neurobiological Technologies Inc pay dividends?
Neurobiological Technologies Inc pays a Notavailable dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Neurobiological Technologies Inc dividends here
What is Neurobiological Technologies Inc’s EPS estimate?
Neurobiological Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurobiological Technologies Inc have?
Neurobiological Technologies Inc has 27,020,000 shares outstanding.
What happened to Neurobiological Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neurobiological Technologies Inc?
Currently, no hedge funds are holding shares in NTII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neurobiological Technologies Inc
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Technical Analysis
Scinai Immunotherapeutics
―
―
Bolt Biotherapeutics
―
Longeveron
―
Pasithea Therapeutics Corp
―
Ownership Overview
―
Insiders
―
Mutual Funds
17.53% Other Institutional Investors
82.47% Public Companies and
Individual Investors